In BPS 115, (Genetics and Pharmacogenetics), first year PharmD students study themselves at a genetic level using pharmacogenetic testing, and volunteer to share their data with each other. Data is aggregated for selected drug metabolizing genes-of-interest. These results are presented on “Reveal Day,” where students role-play doctor-patient consultations and review each “patient’s” proclivity for developing certain conditions and diseases. (See video links, below)
“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM). “This is a huge win for the NHLBI’s TOPMed program, UCSF, and our lab”, said senior author Esteban G. Burchard, MD, MPH.